Gilead Sciences
PulseAugur coverage of Gilead Sciences — every cluster mentioning Gilead Sciences across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Healthcare M&A Surges to $65B Amid Patent Cliffs and Global Innovation
The pharmaceutical industry is experiencing a significant surge in mergers and acquisitions, with $65 billion in deals during the first quarter of 2026. This trend is driven by looming patent expirations for major drugs…
-
Beyond LLMs: Why Scalable Enterprise AI Adoption Depends on Agent Logic
Enterprises are increasingly adopting AI agents for core workflows, but face challenges in ensuring scalability, cost control, and governance. Key issues include the
-
Genesis AI partners with Incyte in $120M drug discovery deal
Genesis Molecular AI has secured a significant partnership with Incyte, a global biotech company, valued at $120 million. This deal includes $80 million in upfront cash and a $40 million equity investment, with potentia…